AMPH vs PODD · P/E 12, rev $732.0M vs P/E 34, rev $2.07B
Amphastar P (AMPH) versus Insulet Corporation (PODD) — a side-by-side from cached financials, not a winner call.
Amphastar P (AMPH) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Insulet Corporation (PODD) is a medical devices company listed on NASDAQ.
Latest reported AMPH revenue for 2024-12-31 was $732.0M. Net income was $159.5M. Revenue was up 13.6% from 2023-12-31 to 2024-12-31. AMPH currently screens at market cap $880.1M and trailing P/E 12.0.
Latest reported PODD revenue for 2024-12-31 was $2.07B. Net income was $418.3M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
AMPH currently screens at market cap $880.1M and trailing P/E 12.0. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
Not investment advice. Open the AMPH and PODD stock pages for the full models.
Not investment advice.